As of 2025-05-15, the EV/EBITDA ratio of Benitec Biopharma Inc (BNTC) is -12.46. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BNTC's latest enterprise value is 268.69 mil USD. BNTC's TTM EBITDA according to its financial statements is -21.56 mil USD. Dividing these 2 quantities gives us the above BNTC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-05-09 | -12.52 |
| 2025-05-08 | -12.65 |
| 2025-05-07 | -12.41 |
| 2025-05-06 | -12.84 |
| 2025-05-05 | -13.47 |
| 2025-05-02 | -14.20 |
| 2025-05-01 | -13.45 |
| 2025-04-30 | -12.47 |
| 2025-04-29 | -12.58 |
| 2025-04-28 | -12.53 |
| 2025-04-25 | -12.47 |
| 2025-04-24 | -12.83 |
| 2025-04-23 | -12.56 |
| 2025-04-22 | -12.70 |
| 2025-04-21 | -12.72 |
| 2025-04-17 | -12.66 |
| 2025-04-16 | -12.54 |
| 2025-04-15 | -12.58 |
| 2025-04-14 | -12.09 |
| 2025-04-11 | -11.34 |
| 2025-04-10 | -10.52 |
| 2025-04-09 | -10.79 |
| 2025-04-08 | -9.67 |
| 2025-04-07 | -10.61 |
| 2025-04-04 | -10.97 |
| 2025-04-03 | -11.79 |
| 2025-04-02 | -11.24 |
| 2025-04-01 | -10.61 |
| 2025-03-31 | -11.79 |
| 2025-03-28 | -12.28 |
| 2025-03-27 | -12.63 |
| 2025-03-26 | -12.97 |
| 2025-03-25 | -13.75 |
| 2025-03-24 | -13.36 |
| 2025-03-21 | -15.46 |
| 2025-03-20 | -16.27 |
| 2025-03-19 | -14.93 |
| 2025-03-18 | -14.76 |
| 2025-03-17 | -14.55 |
| 2025-03-14 | -14.11 |
| 2025-03-13 | -13.91 |
| 2025-03-12 | -13.54 |
| 2025-03-11 | -12.12 |
| 2025-03-10 | -10.91 |
| 2025-03-07 | -11.76 |
| 2025-03-06 | -11.76 |
| 2025-03-05 | -10.83 |
| 2025-03-04 | -10.55 |
| 2025-03-03 | -11.09 |
| 2025-02-28 | -11.43 |